This chapter provides an introduction in experience sampling methods (ESM) and illustrates its valuable contribution to traditional methods assessing quality of life in schizophrenia. Despite its dynamic nature and interactions with daily life, quality of life is usually measured with retrospective self-report questionnaires or interviews in a clinical setting. Disadvantageous to this approach is that the ecological validity of traditional questionnaires is limited and the reliability of retrospective assessment methods can be questioned. Experience sampling methods allow studying patients’ experiences in their daily life. By assessing positive and negative affect in real time, it provides additional valuable knowledge concerning real-life influences and fluctuations in subjective well-being. During a week, on multiple times a day, patients respond to a signal, by filling out questionnaires regarding their mood, thoughts, and context. Electronic technology facilitates the usability of ESM by offering the signals as well as the data collection on the same pocket-size device. ESM outcomes provide valuable insights at both individuals as group level and are therefore a useful addition to traditional assessment methods, for both research and treatment purposes in schizophrenia.
Negative Affect Emotional Experience Satisfaction With Life Scale Experience Sampling Method Daily Life Experience
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Andrews FM, McKennell AC. Measures of self-reported well-being: their affective, cognitive, and other components. Soc Indic Res. 1980;8(2):127–55.CrossRefGoogle Scholar
Barge-Schaapveld DQ, Nicolson NA. Effects of antidepressant treatment on the quality of daily life: an experience sampling study. J Clin Psychiatry. 2002;63(6):477–85.CrossRefPubMedGoogle Scholar
De Haan L, Lavalaye J, Linszen D, et al. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone. Am J Psychiatry. 2000;157:1019–20. doi:10.1176/appi.ajp.157.6.1019.CrossRefPubMedGoogle Scholar
De Haan L, Van Bruggen M, Lavalaye J, et al. Subjective experience and D 2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study. Am J Psychiatry. 2003;160:303–9. doi:10.1176/appi.ajp.160.2.303.CrossRefPubMedGoogle Scholar
Delespaul PA. Assessing schizophrenia in daily life – the experience sampling method. Maastricht: University press; 1995.Google Scholar
Hedeker D, Mermelstein RJ, Demirtas H. An application of a mixed-effects location scale model for analysis of Ecological Momentary Assessment (EMA) data. Biometrics. 2008;64:627–34.CrossRefPubMedGoogle Scholar
Lataster J, Van Os J, De Haan L, et al. Emotional experience and estimates of D2 receptor occupancy in psychotic patients treated with haloperidol, risperidone, or olanzapine: an experience sampling study. J Clin Psychiatry. 2011;72:1397–404. doi:10.4088/JCP.09m05466yel.CrossRefPubMedGoogle Scholar
Lepage M, Sergerie K, Pelletier M, et al. Episodic memory bias and the symptoms of schizophrenia. Can J Psychiatry. 2007;52(11):702–9.PubMedGoogle Scholar
Mizrahi R, Rusjan P, Agid O, et al. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry. 2007;164:630–7. doi:10.1176/appi.ajp.164.4.630.CrossRefPubMedGoogle Scholar